Assessment of disseminated pancreatic cancer: A comparison of traditional exploratory laparotomy and radioimmunoguided surgery

Surgery

Volumn 122, Issue 5, 1997, Pages 867-873

  LaValle, Gregory J ^a,b   Martinez, Deborah A ^a,b   Sobel, Denise ^a,b   DeYoung, Barry ^a,b   Martin Jr , Edward W ^a,b  

^a Arthur G James Cancer Hospital ^*  (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; MONOCLONAL ANTIBODY CC49;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LYMPH NODE METASTASIS; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHENOTYPE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SURGICAL TECHNIQUE;

EID: 0030667166     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90326-3     Document Type: Article

References (21)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1997. CA 1997;47:5-27.
2. Johnstone PA, Sindelar WF. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial. Int J Radiat Oncol Biol Phys 1993;27:831-4.
3. Kayahara M, Takukazu N, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72:2118-23.
4. Sarr MG, Cameron JL. Surgical management of unresectable carcinoma of the pancreas. Surgery 1982;91:123-33.
5. Menke-Pluymers MBE, Klinkenbijl JHG, Tijoe M, Jeekel J. Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer. Hepatogastroenterology 1992;39:429-31.
6. Selch MT, Parker RG. Results in the management of locally unresectable pancreatic carcinoma. Am J Clin Oncol 1986;9:139-45.
7. Ahlgren JD. Chemotherapy for pancreatic carcinoma. Cancer 1996;78(suppl):654-63.
8. Moore M. Activity of gemcitibine in patients with advanced pancreatic carcinoma. Cancer 1996;78(suppl):633-8.
9. Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle G, et al. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second generation monoclonal antibody. Ann Surg 1992;216:627-32.
10. Schneebaum S, Arnold MW, Houchens D, et al. The importance of intraoperative periportal lymph node metastasis identification. Cancer 1996;77:613-20.
11. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563-9.
12. Molinolo A, Simpson JF, Thor A, Schlom J. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Cancer Res 1990;50:1291-8.
13. Maeda M, Shoji M, Kawagoshi T, Futatsuya R, Honda T, Brady LW. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4. Cancer 1994;73(suppl):800-7.
14. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 1994;74:1595-600.
15. International (ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-8.
16. Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary metastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-7.
17. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastasis. Adv Cancer Res 1978;28:149-250.
18. Weiss L. Random and nonrandom processes in metastasis and metastatic inefficiency. Invasion Metastasis 1983;3:193-207.
19. Glaves D, Ketch DA, Asch BB. Conservation of epithelial cell phenotypes during hematogenous metastasis from mammary carcinomas. JNCI 1986;76:933-7.
20. Wilkinson EJ, Hause L. Probability in lymph node sectioning. Cancer 1974;33:1269-74.
21. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118-24.